Why Tandem Diabetes Care, Inc.’s (TNDM) Stock Is Up 9.31%
As of Friday, August 07, Tandem Diabetes Care, Inc.’s TNDM share price has surged by 9.31%, which has investors questioning if this is right time to sell.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Tudor Pop
Rosalio Madrigal
Jenna Brashear
Rosalio Madrigal
| Share Statistics | TNDM | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,274.0 | $397.9 | 48% |
|
| Shares Out (Mil) | 69.0 | 40.8 | 55% |
|
| Institutional Ownership | 99.1% | 83.6% | 85% |
|
| Float (Mil) | 63.8 | 35.5 | 52% |
|
| Beta | 1.54 | 0.88 | 83% |
|
| Avg Daily Volume (000s) | 1,342 | 323 | 77% |
|
| Price Change (52-week) |
45.8% | 63.7% | 80% |
|
| Growth | TNDM | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.3% | 11.8% | 73% |
|
| Net Income (5yr) | (42.9%) | (5.8%) | 9% |
|
| EPS (5yr) | (40.1%) | 10.4% | 5 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (14.7%) | (15.5%) | 55% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 19 | 20 | 20 | |
| Current EPS | ($0.242) | ($0.667) | $0.171 | |
| Month Ago EPS | ($0.241) | ($0.675) | $0.175 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | ($0.190) | ($0.706) | $0.059 | |
| Year/Year Chg | (21.2%) | (78.1%) | (128.4%) | |
| Financials | TNDM | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,041 | $119 | 51% |
|
| Net Income (TTM) (Mil) | ($63) | ($9) | 14% |
|
| EPS (TTM) | ($0.927) | ($0.400) | 22% |
|
| Operating Cash Flow (TTM) (Mil) | ($6) | ($3) | 24% |
|
| Net Cash Flow (TTM) (Mil) | ($1) | $1 | 39% |
|
| Long-Term Debt (Q1) (Mil) | $719 | $23 | 62% |
|
| Enterprise Value (Q1) (Mil) | $1,836 | $371 | 48% |
|
| Valuation | TNDM | Industry Median |
Percentile (All Stocks) |
|
| P/B | 9.74 | 2.73 | 90% |
|
| P/E | na | 25.4 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.4 | na |
|
| Ratios | TNDM | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 56.0% | 58.3% | 68% |
|
| Net Margin | (6.1%) | (6.9%) | 24% |
|
| ROA | (6.2%) | (12.7%) | 28% |
|
| ROE | (48.0%) | (12.3%) | 16% |
|
| Liabilities to Assets | 88.7% | 46.0% | 83% |
|
| F-Score | 4 | 4 | 33% |
|
Tandem Diabetes Care, Inc. did not pass any screens on 9/10/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors